Achieve life sciences reports qtrly loss per share $0.11

Achieve reports financial results for first quarter 2020 and provides update on cytisinicline development program.achieve life sciences inc qtrly loss per share $0.11.
ACHV Ratings Summary
ACHV Quant Ranking